0000950170-24-062570.txt : 20240520 0000950170-24-062570.hdr.sgml : 20240520 20240520180557 ACCESSION NUMBER: 0000950170-24-062570 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240516 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROVES REGINA E CENTRAL INDEX KEY: 0001653877 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 24966293 MAIL ADDRESS: STREET 1: 5751 COPLEY DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4399 SANTA ANITA AVE CITY: EL MONTE STATE: CA ZIP: 91731 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 ownership.xml 4 X0508 4 2024-05-16 false 0001674930 Fulgent Genetics, Inc. FLGT 0001653877 GROVES REGINA E C/O FULGENT GENETICS, INC. 4399 SANTA ANITA AVENUE EL MONTE CA 91731 true false false false false Common Stock 2024-05-16 4 A false 4000 0 A 8000 D Stock Option (Right to Buy) 22.50 2024-05-16 4 A false 5481 0 A 2034-05-15 Common Stock 5481 5481 D Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to continued service for Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after May 16, 2024, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. /s/ Paul Kim as Attorney-in-Fact 2024-05-20